
Mainz BioMed (NASDAQ: $MYNZ) develops market-ready molecular genetic diagnostic solutions for life-threatening conditions, such as #colorectal cancer.
Mainz, Germany
Joined November 2021
- Tweets424
- Following1.2K
- Followers8.1K
- Likes185
Mainz BioMed (NASDAQ: MYNZ) retweeted
Replying to @GoHealio
@GoHealio host @ShikhaJainMD sits down with @MainzBioMed CEO, Guido Baechler, to discuss the balance of best performance of screening programmes with affordability.
#HealthCare #HealthcareTechnology #Cancer #CancerDetection #CancerPrevention
buff.ly/3Jp9sbE
Mainz BioMed (NASDAQ: MYNZ) retweeted
Hear Oncology Overdrive host, @ShikhaJainMD discuss with @MainzBioMed’s Guido Baechler: How do you balance the best possible performance of screening programs with affordable tests?
Listen now: bit.ly/3RxRw1Y
Mainz BioMed (NASDAQ: MYNZ) retweeted
We are initiating coverage of @MainzBioMed ($MYNZ) which is focused on the development and commercialization of in vitro molecular genetic diagnostic tests in oncology. Details in the #HCWCO Morning Summary; bit.ly/3sxypaP
#HealthcareInvestors
Mainz BioMed (NASDAQ: MYNZ) retweeted
Mainz Biomed & Dante Labs Partner for Commercialization of ColoAlert in Europe and the United Arab Emirates mainzbiomed.com/mainz-biomed… @MainzBioMed @DanteLabs More European life science business news at [LSE] at life-sciences-europe.com/new…
Mainz BioMed (NASDAQ: MYNZ) retweeted
🩺 The #biotech #stock detecting #cancer early & increasing survival rates significantly
🧬 @MainzBioMed $MYNZ develops molecular genetic diagnostic tests for #ColorectalCancer, #PancreaticCancer & pre-cancer indicators
🔗 youtu.be/t6I-qJmKo5Q #stockstowatch #StocksInFocus
Mainz BioMed (NASDAQ: MYNZ) retweeted
Top Stocks To Invest In Right Now? 5 Health Care Stocks To Watch stockmarket.com/featured/top… #healthcare #biotech #stockmarket #stocks #investing #stockstowatch
Mainz BioMed (NASDAQ: MYNZ) retweeted
Join us as we catch up with Guido Baechler, CEO & Director of @MainzBioMed (NASDAQ: $MYNZ), on their recent partnership with @Precision4Med that will expedite the FDA approval process on their breakthrough early-detection cancer screening tool.
🖥 youtu.be/uVbKj5Yb5pc.
Mainz BioMed (NASDAQ: MYNZ) retweeted
Mainz Biomed Expands ColoAlert Commercialization with Ganzimmun Diagnostics in Europe mainzbiomed.com/news/ @MainzBioMed @ganzimmun More European life science business news at [LSE] at life-sciences-europe.com/new…
Mainz BioMed (NASDAQ: MYNZ) retweeted
If you're #investing in biotech, you need to be watching @MainzBioMed (NASDAQ: MYNZ).
Watch our exclusive interview with CEO & Director Guido Baechler discussing the tool that put them on the market and their plans for the future.
🖥: youtu.be/jd39nCAhm9k.
#DearRetail




![[iito] Life Science (@iitoLifeScience) profile picture](https://pbs.twimg.com/profile_images/555518370523525120/54L7-_yi_400x400.jpeg)
![Image from [iito] Life Science (@iitoLifeScience)](https://pbs.twimg.com/media/FTGr1eMXEAEmRuP.jpg?name=small&format=webp)



![Image from [iito] Life Science (@iitoLifeScience)](https://pbs.twimg.com/media/FGjv9IlXsAQayH6.jpg?name=small&format=webp)

